Search Form
Now choose a category »

Public Statements

Red Tape Reduction and Small Business Job Creation Act

Floor Speech

By:
Date:
Location: Washington, DC

BREAK IN TRANSCRIPT

Mr. FINCHER. Madam Chair, I rise in strong support of Mr. Fitzpatrick's amendment.

Madam Chair, unemployed Americans are crying out for more jobs, urging Congress to review rules and regulations that stifle innovation, economic growth, and job creation. Overly burdensome regulations are hurting business expansion, which is why we are debating this bill this evening. Overly burdensome regulations is also why I introduced H.R. 3213, the Small Company Job Growth and Regulatory Relief Act, to expand Sarbanes Oxley 404(b) exemptions for companies with a public float of less than $350 million.

Supporters of increasing the current $75 million exemptions from Sarbanes Oxley 404(b) for small companies would save duplicative audit costs, which hinder many companies from going public. Going public provides opportunities for companies to raise needed capital in order to expand, reinvest, and create jobs.

Providing a permanent exemption for Sarbanes Oxley for companies with a public float of $250 million or less just makes good sense. I strongly encourage my colleagues to support this amendment.

BREAK IN TRANSCRIPT

Mr. FINCHER. Madam Chairman, I rise in strong support of Mr. Manzullo's amendment, which urges the Federal Government to develop scientific integrity policies when a Federal agency implements a rule or regulation. Science should be at the heart of Federal agency decision-making.

Right now, the pork producers in my State and others in agriculture are fighting the FDA's concerns regarding antibiotic use in animals when there is no scientific evidence behind those concerns. This is why I had originally introduced House Resolution 98 last year, which would send a bipartisan, commonsense message to the Food and Drug Administration to rely on scientific fact in its development of rules and regulations.

Mr. Manzullo's amendment goes further, guiding all agencies on a path towards scientific integrity, not just the FDA.

I would like to remind my colleagues that Americans are constantly facing the challenge of widespread and needless interventions in their life. Why let this continue through our agencies' misuse of science?

I urge my colleagues to support the Manzullo amendment.

BREAK IN TRANSCRIPT


Source:
Skip to top
Back to top